Clinical Trials Directory

Trials / Completed

CompletedNCT03052101

Assessment of Safety of Air Travel in Patients With Pulmonary Langerhans Cell Histiocytosis

Status
Completed
Phase
Study type
Observational
Enrollment
94 (actual)
Sponsor
University of Cincinnati · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to conduct survey-based assessments for the safety of air travel in patients with pulmonary Langerhans cell histiocytosis (PLCH). The study will enroll patients through the clinic network at Rare Lung Disease Consortium (RLDC) and through the Histiocytosis Association website. Patients will have access to the questionnaire via REDCap (an online data management system) and each patient will be provided with a link to complete the survey. The investigators plan on enrolling approximately 200 patients with PLCH for the purpose of this study. Secondary aims of this study include further characterization of the clinical aspects of disease and to establish a contact registry for these patients, in order to facilitate future studies.

Detailed description

The study will enroll participants through the clinic network at the Rare Lung Disease Consortium (RLDC) and through the Histiocytosis Association websites. Participants will have access to the questionnaire via REDCap (an online data management system) and each participant will be provided a link to complete the survey. In case of lack of internet access or inability to complete the online questionnaire, a paper survey will be mailed out with a pre-paid envelope to return the survey. Primary Study Objective(s): To define the risk of pneumothorax associated with air travel in patients with PLCH. Secondary Study Objective(s): To establish a contact registry for patients with PLCH to facilitate future trials To assess the rate of pneumothorax recurrence in patients with PLCH To assess the efficacy of pleurodesis in preventing recurrent pneumothoraces among patients with PLCH

Conditions

Timeline

Start date
2016-06-01
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2017-02-14
Last updated
2024-01-31
Results posted
2024-01-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03052101. Inclusion in this directory is not an endorsement.